These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34063655)

  • 1. Preliminary Study of ADHD Biomarkers in Adults with Focus on Serum Iron and Transcranial Sonography of the Substantia Nigra.
    Bahn GH; Lee SM; Hong M; Lee SY
    Int J Environ Res Public Health; 2021 May; 18(9):. PubMed ID: 34063655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased echogenicity of the substantia nigra in children and adolescents with attention-deficit/hyperactivity disorder.
    Krauel K; Feldhaus HC; Simon A; Rehe C; Glaser M; Flechtner HH; Heinze HJ; Niehaus L
    Biol Psychiatry; 2010 Aug; 68(4):352-8. PubMed ID: 20227683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural abnormality of the substantia nigra in children with attention-deficit hyperactivity disorder.
    Romanos M; Weise D; Schliesser M; Schecklmann M; Löffler J; Warnke A; Gerlach M; Classen J; Mehler-Wex C
    J Psychiatry Neurosci; 2010 Jan; 35(1):55-8. PubMed ID: 20040247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative transcranial sonography in Wilson's disease and healthy controls: Cut-off values and functional correlates.
    Tribl GG; Trindade MC; Almeida KJ; Alves RC; de Andrade DC; Fonoff ET; Machado AA; Teixeira MJ; Barbosa ER; Bor-Seng-Shu E
    J Neurol Sci; 2018 Feb; 385():69-74. PubMed ID: 29406916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
    Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
    Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.
    Berg D; Roggendorf W; Schröder U; Klein R; Tatschner T; Benz P; Tucha O; Preier M; Lange KW; Reiners K; Gerlach M; Becker G
    Arch Neurol; 2002 Jun; 59(6):999-1005. PubMed ID: 12056937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
    Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
    Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage.
    Berg D
    J Neural Transm (Vienna); 2006 Jun; 113(6):775-80. PubMed ID: 16755382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Deficiency Parameters in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Percinel I; Yazici KU; Ustundag B
    Child Psychiatry Hum Dev; 2016 Apr; 47(2):259-69. PubMed ID: 26092605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantia nigra echogenicity is associated with serum ferritin, gender and iron-related genes in Parkinson's disease.
    Li K; Ge YL; Gu CC; Zhang JR; Jin H; Li J; Cheng XY; Yang YP; Wang F; Zhang YC; Chen J; Mao CJ; Liu CF
    Sci Rep; 2020 May; 10(1):8660. PubMed ID: 32457446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
    Hennissen L; Bakker MJ; Banaschewski T; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Hollis C; Kovshoff H; McCarthy S; Nagy P; Sonuga-Barke E; Wong IC; Zuddas A; Rosenthal E; Buitelaar JK;
    CNS Drugs; 2017 Mar; 31(3):199-215. PubMed ID: 28236285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between systemic iron parameters and substantia nigra iron stores in restless legs syndrome.
    Garcia-Malo C; Novo-Ponte S; Castro-Villacañas Farzamnia A; Boi S; Miranda Castillo C; Romero Peralta S; Martínez Vidal V; Botta L; Anguizola S; Cano-Pumarega I; Garcia-Borreguero D
    Sleep Med; 2021 Sep; 85():191-195. PubMed ID: 34343769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal decrease in substantia nigra echogenicity. Implications for the pathogenesis of Parkinson's disease.
    Iova A; Garmashov A; Androuchtchenko N; Kehrer M; Berg D; Becker G; Garmashov Y
    J Neurol; 2004 Dec; 251(12):1451-4. PubMed ID: 15645343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).
    Prati P; Bignamini A; Coppo L; Naldi A; Comi C; Cantello R; Gusmaroli G; Walter U
    J Neural Transm (Vienna); 2017 Jul; 124(7):869-879. PubMed ID: 28451942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
    Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
    Wu EQ; Birnbaum HG; Zhang HF; Ivanova JI; Yang E; Mallet D
    J Manag Care Pharm; 2007 Sep; 13(7):561-9. PubMed ID: 17874862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
    Su Y; Yang L; Stein MA; Cao Q; Wang Y
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Ferritin on Short-Term Treatment Response in Attention Deficit Hyperactivity Disorder.
    Oner P; Oner O; Cop E; Munir KM
    Klinik Psikofarmakol Bulteni; 2012; 22(4):325-331. PubMed ID: 28804252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial Sonography in Mitochondrial Membrane Protein-Associated Neurodegeneration.
    Skowronska M; Kmiec T; Czlonkowska A; Kurkowska-Jastrzębska I
    Clin Neuroradiol; 2018 Sep; 28(3):385-392. PubMed ID: 28352978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.